New York, July 18, 2019 (GLOBE NEWSWIRE) -- The technological advancements in the health care sector, increased in rate of occurrence of cancer, and rise in investment in research and developments in neurobiology is boosting the market for cell surface markers.

The Global Cell Surface Markers Market is forecast to reach USD 965.0 Million by 2026, according to a new report by Reports and Data. Technological advancements in the healthcare sector have primarily fueled the growth of the market. Integration of additional parameters to traditional instruments that can help in in-depth analysis in biotechnological R&D is boosting the growth of the market. The expansion of the market has also been the result of, increased investments by key players of the market for instrumental advancements with, automated techniques and solutions for disease identification and prognosis. One of such mentionable improvements in the market in 2018 is the significant investment made by GenScript, one of the key players of the market, on the project- Novel HIV Vaccine. Such emphasis on the enhancement of Novel HIV Vaccine and the associated rise in the number of researches is also boosting the growth of the cell surface markers market.

Changes in lifestyle have resulted in the increased occurrence of oncological and cell-associated diseases that demands advancements in monoclonal antibody generation and production. The increased need for improvements in antibody generation and production is having a positive impact on the growth of the market.

North America leads the global cell surface markers market. The rise in the occurrence rate of cancer and increased emphasis on drug development and discovery in this region have contributed to its market dominance. Europe is another major region for this market, which follows North America in context to its market share. The presence of market leaders in this region is one of the major contributing factors for its market share. 

Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/1552

Further key findings from the report suggest

  • In the year 2018, the global cell surface markers market held a market share of USD 525.0 Million, which is forecasted to witness a growth rate of 7.54% during the forecast period.
  • There have been significant advancements in the recent years, in the techniques and high-throughput tools that are required for cytological evaluation. Such advancements in the cytological evaluation are boosting the growth of the cell surface markers market.
  • In the context of cell type, the T Cell Surface Markers segment dominated the market that generated the highest revenue of USD 199.5 Million in 2018, with a growth rate of 7.9% during the forecast period. In case of infections, pathogens proliferate and activate the T cells. As a result, the T Cell Surface Markers segment turns out to be useful in identifying any infection, which has resulted in its increased use for diagnostic purpose that has a positive impact on its market share. 
  • In regards to the products, the Antibodies segment can be seen to lead the market that yielded the higher revenue of USD 346.5 Million in 2018 with the higher growth rate of 7.9% during the forecast period. The revenue yielded by this segment has been attributed to the increased number of neurobiology researches that requires reliable and accurate antibodies.
  • In the context of source, the Mice segment generated the highest revenue of USD 294.0 Million in 2018 with the highest growth rate of 8.0% during the forecast period. This source is one of the most cost-effective sources for antibody production, which is a significant reason for the growth rate of this segment.
  • In regards to application, the Research Applications segment can be seen to be dominating the market that occupied a market share of 65% in 2018 with a growth rate of 7.1% during the forecast period. The market dominance of this segment has been the result of the rise in use of cell surface markers in stem cell, cancer, and HIV care, the associated growth in cell surface marker-based research and increased private and public funding in these researches.
  • In context to end-users, the market is led by the Academic & Research Institutes segment that held the largest market share of 48% in 2018 with a growth rate of 7.8% during the forecast period. Factors resulting in the market dominance of this segment is the result of the increased number of researches for drug discovery and elevated emphasis on identifying novel drug targets for chronic conditions. 
  • In the global cell surface markers market, the Asia Pacific region is forecasted to witness the highest growth rate of 8.9% during the forecast period. The growth rate of this region has been driven by a significant rise in investments for R&D in the healthcare sector and unmet healthcare and medical needs.
  • Key participants include Janssen Diagnostics, Inc, Thermo Fisher Scientific, Inc., Siemens Healthcare, Nihon Kohden Corporation, Bio-Techne, Genscript, F. Hoffman-La Roche, Danaher Corporation, Thermo Fisher Scientific, Abcam, Becton, Dickinson and Company, Qiagen N.V.

To identify the key trends in the industry, click on the link below:   https://www.reportsanddata.com/report-detail/cell-surface-markers-market

Segments covered in the report:

For the purpose of this report, Reports and Data have segmented the global cell surface markers market based on Cell Type, Product, Source, Instrument, and Reagent Type, Application, End-users, and Region:                     

Cell Type Outlook (Revenue, USD Million; 2016-2026)

  • T Cell Surface Markers
  • NK Cell Surface Markers
  • B Cell Surface Markers
  • Monocyte Cell Surface Markers
  • Others

Product Type Outlook (Revenue, USD Million; 2016-2026)

  • Antibodies
  • Pcr Arrays

Source Type Outlook (Revenue, USD Million; 2016-2026)

  • Rats
  • Mice
  • Others

Instrument and Reagent Type Outlook (Revenue, USD Million; 2016-2026)

  • Flow Cytometer
  • Reagents and Kits
  • Hematology Analyzers

Application Type Outlook (Revenue, USD Million; 2016-2026)

  • Research Applications
    • Drug Discovery
    • Stem Cell Research
    • Immunology
  • Medical Applications
    • Oncology

End-users Type Outlook (Revenue, USD Million; 2016-2026)

  • Clinical Testing Laboratories & Hospitals
  • Academic & Research Institutes
  • Biotechnology & Pharmaceutical Companies

Order Now: https://www.reportsanddata.com/checkout-form/1552

Regional Outlook (Volume, Kilo Tons; 2016-2026 and Revenue, USD Million; 2016-2026)

  • North America:
    • USA
    • Canada
  • Asia Pacific:
    • India
    • China
    • Japan
    • Rest of Asia Pacific
  • Middle east and Africa
  • Latin America:
    • Brazil
  • Europe:
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe

Browse more reports of Pharmaceutical category at:  https://www.reportsanddata.com/report/category/biotechnology

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-800-819-3052
E-mail: sales@reportsanddata.com